Ginger Appleberry, International Partner, Locke Lord LLP to Speak at KCís Understanding FDA Guidance on Mobile Medical Applications Live Webcast
New York, NY, May 07, 2014 --(PR.com
)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Ginger Appleberry, International Partner, Locke Lord LLP will speak at the Knowledge Congress’ webcast entitled: “Understanding FDA Guidance on Mobile Medical Applications.” This event is scheduled for May 14, 2014 from 12:00pm – 2:00pm (ET).
For further details, please visit:
About Ginger Appleberry
Ginger Appleberry is an International Partner with Locke Lord LLP. She is a member of the Business Litigation and Health Care practice groups. Ms. Appleberry has experience defending pharmaceutical companies and device manufactures in False Claims Act and qui tam lawsuits including government investigations regarding pharmaceutical pricing, marketing, promotion and regulatory issues. She regularly advises clients in connection with the development, registration, protection, and enforcement of trademarks and copyrights. Ms. Appleberry also has significant experience with trust and estate litigation, fiduciary litigation, products liability, and complex commercial litigation.
About Locke Lord LLP
Locke Lord is well-known nationally for its skill in the health care industry. Our health care practice litigation team includes trial lawyers who routinely represent the interests of multi-national pharmaceutical companies, medical device companies, managed care, health plan and health care insurers, hospitals, multi-hospital health systems, physicians and physician groups, academic medical centers, skilled nursing centers, and home health, hospice, and long term care facilities in a range of litigation, investigations, civil investigative demand (CID) proceedings, and threatened litigation, including high-profile matters involving billion dollar claims and cutting-edge issues. They work in tandem with the Firm’s more than 650 lawyers in 11 U.S. offices, Hong Kong and London.
On September 23, 2013, the U.S. Food and Drug Administration (FDA) issued the final guidance for mobile medical applications, confirming that the federal agency views such products to be within its regulatory authority. The guidance clarifies the focus of the regulatory activity as it pertains to a specific set of apps. All Companies should have a complete and thorough understanding of the particulars of the final rule to avoid costly errors and penalties.
The Knowledge Group has assembled a panel of key thought leaders and practitioners to provide the audience with an in-depth analysis of the final guidance on mobile medical applications.
In a two-hour live webcast, speakers will discuss:
• Mobile Medical Applications: An Overview
• How will the FDA regulate mobile medical apps?
• Mobile medical apps that the FDA will regulate
• Mobile apps for which the FDA intends to exercise enforcement discretion
• Does the FDA regulate mobile devices and mobile app stores?
• Does the guidance apply to electronic health records?
• Impact of the Final Rule
• Penalties and Exemptions
• Enforcement and Best Practices in Compliance
• Latest Regulatory Updates
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org